[go: up one dir, main page]

YU137083A - Process for preparing alkylesters of 6-chloro-or 6-bromo-1,2-dihydro-3h-pyrrolo(1,2-a)pyrrol-1-carboxylic acid - Google Patents

Process for preparing alkylesters of 6-chloro-or 6-bromo-1,2-dihydro-3h-pyrrolo(1,2-a)pyrrol-1-carboxylic acid

Info

Publication number
YU137083A
YU137083A YU01370/83A YU137083A YU137083A YU 137083 A YU137083 A YU 137083A YU 01370/83 A YU01370/83 A YU 01370/83A YU 137083 A YU137083 A YU 137083A YU 137083 A YU137083 A YU 137083A
Authority
YU
Yugoslavia
Prior art keywords
bromo
chloro
pyrrolo
dihydro
alkylesters
Prior art date
Application number
YU01370/83A
Other languages
English (en)
Inventor
J M Muchowski
A F Kluge
Original Assignee
Syntex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex Inc filed Critical Syntex Inc
Publication of YU137083A publication Critical patent/YU137083A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/337Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
YU01370/83A 1980-06-09 1983-06-22 Process for preparing alkylesters of 6-chloro-or 6-bromo-1,2-dihydro-3h-pyrrolo(1,2-a)pyrrol-1-carboxylic acid YU137083A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/157,719 US4344943A (en) 1980-06-09 1980-06-09 6-Chloro- or 6-bromo-1,2-dihydro-3H-pyrrolo[1,2-a]-pyrrole-1-carboxylic acids and derivatives thereof

Publications (1)

Publication Number Publication Date
YU137083A true YU137083A (en) 1983-12-31

Family

ID=22564979

Family Applications (2)

Application Number Title Priority Date Filing Date
YU1423/81A YU43235B (en) 1980-06-09 1981-06-05 Process for preparing 6-chloro-or 6-bromo-1,2-dihydro-3h-pyrrolo(1,2-a)pyrrol-1-carboxylic acid and alkyl esthers thereoff
YU01370/83A YU137083A (en) 1980-06-09 1983-06-22 Process for preparing alkylesters of 6-chloro-or 6-bromo-1,2-dihydro-3h-pyrrolo(1,2-a)pyrrol-1-carboxylic acid

Family Applications Before (1)

Application Number Title Priority Date Filing Date
YU1423/81A YU43235B (en) 1980-06-09 1981-06-05 Process for preparing 6-chloro-or 6-bromo-1,2-dihydro-3h-pyrrolo(1,2-a)pyrrol-1-carboxylic acid and alkyl esthers thereoff

Country Status (19)

Country Link
US (1) US4344943A (xx)
EP (1) EP0041711B1 (xx)
JP (1) JPS5714591A (xx)
KR (1) KR850000609B1 (xx)
AT (1) ATE12771T1 (xx)
AU (1) AU546012B2 (xx)
CA (1) CA1178277A (xx)
DE (1) DE3169956D1 (xx)
DK (1) DK249781A (xx)
ES (1) ES8203376A1 (xx)
GR (1) GR74615B (xx)
HU (1) HU185430B (xx)
IE (1) IE51523B1 (xx)
IL (1) IL63047A (xx)
NZ (1) NZ197331A (xx)
PT (1) PT73154B (xx)
SU (1) SU1217260A3 (xx)
YU (2) YU43235B (xx)
ZA (1) ZA813829B (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4457941A (en) * 1982-03-22 1984-07-03 Syntex (U.S.A.) Inc. Use of pyrrolo-pyrrole in treating microvascular diseases associated with diabetes
US4454151A (en) * 1982-03-22 1984-06-12 Syntex (U.S.A.) Inc. Use of pyrrolo pyrroles in treatment of ophthalmic diseases
US4612325A (en) * 1982-06-08 1986-09-16 Syntex (U.S.A) Inc. 5-Aroyl-6-alkylthio-1,2-dihydro-3H-pyrrolo(1,2-A)pyrrole-1-carboxylic acids and use thereof as analgesics and anti-inflammatories
US4511724A (en) * 1982-06-10 1985-04-16 Merck & Co., Inc. 5-(Pyrrol-2-oyl)-1,2-dihydro-3H-pyrrolo [1,2-a]pyrrole derivatives as anti-inflammatory and analgesic agents
US4874872A (en) * 1987-01-14 1989-10-17 Syntex (U.S.A.) Inc. Process for preparing (+)-2,3-dihydro-1H-pyrrolo[1,2-A]pyrrole-1,7-dicarboxylates
US4835288A (en) * 1987-01-14 1989-05-30 Syntex Inc. Process for preparing (+)-2,3-dihydro-1H-pyrrolo[1,2-a]pyrrole-1,7-dicarboxylates
HU198927B (en) * 1987-01-14 1989-12-28 Richter Gedeon Vegyeszet Process for producing 1-/substituted aminomethyl/-octa-hydroindolo-(2,3-a)quinolizine derivatives, pharmaceutically applicable acid addition salts thereof, as well as pharmaceutical compositions comprising same
US4849526A (en) * 1987-01-14 1989-07-18 Syntex (U.S.A.) Inc. Process for preparing (±)-2,3-dihydro-1H-pyrrolo[1,2-A]pyrrole-1,7-dicarboxylates
US4874871A (en) * 1987-03-25 1989-10-17 Syntex (U.S.A.) Inc. Process for preparing (+)-2,3-Dihydro-1H-pyrrolo[1,2-a]pyrrole-1-carboxylic acid and related compounds
JP2649168B2 (ja) * 1988-02-25 1997-09-03 久光製薬株式会社 新規な5,6−ジフェニル−1,2−ジヒドロ−3H−ピロロ[1,2−a]ピロール−1−カルボン酸誘導体
US5082950A (en) * 1990-10-12 1992-01-21 Syntex (U.S.A.) Inc. Process for preparing 5-aroyl-2,3-dihydro-1H-pyrrolizine-1,1-dicarboxylates (II) and intermediates therefor
EP0707465A4 (en) * 1993-07-08 1997-04-16 Cygnus Therapeutic Systems MONOLITHIC MATRIX TRANSDERMAL DELIVERY SYSTEM
US5621115A (en) * 1996-02-21 1997-04-15 Ohmeda Pharmaceutical Products Division Inc. Methods for preparing 5-aroyl-1,2-dihydro-3H-pyrrolo-[1,2-A]pyrrole-1-carboxylic acids
US6191285B1 (en) 1997-07-03 2001-02-20 Abbott Laboratories Process for the preparation of ketorolac tromethamine
OA12162A (en) * 2000-01-19 2006-05-08 Cadila Healthcare Ltd Novel compounds having hypolipedemic, hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them.
WO2002062341A1 (en) * 2001-02-07 2002-08-15 University Of Florida Method and composition for the control of hair growth

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4087539A (en) * 1976-07-14 1978-05-02 Syntex (U.S.A.) Inc. 5-(2-Furoyl)-, 5-(2-thenoyl)-, 5-(3-furoyl)- and 5-(3-thenoyl)-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acid derivatives and process for the production thereof
US4089969A (en) * 1976-07-14 1978-05-16 Syntex (U.S.A.) Inc. 5-Aroyl-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acid derivatives and process for the production thereof
JPS539788A (en) * 1976-07-14 1978-01-28 Syntex Inc 55aloyll1*22dihydroo3hh pyroro *1*22a* pyroll11 carboxylic acid derivative
US4097579A (en) * 1977-03-31 1978-06-27 Syntex (U.S.A.) Inc. 5-(2-Pyrroyl)-1,2-dihydro-3H-pyrrolo 1,2-a!pyrrole-1-carboxylic acid derivatives and process for the production thereof
US4140698A (en) * 1977-07-25 1979-02-20 Syntex (Usa) Inc. 1,2-Dihydro-3H-pyrrolo[1,2-a]pyrrole-1-nitriles
US4232038A (en) * 1979-08-31 1980-11-04 Syntex (U.S.A.) Inc. 5-Alkylsulfinylbenzoyl- and 5-alkylsulfonylbenzoyl-1,2-dihydro-3H-pyrrolo[1,]pyrrole-1-carboxylic acids

Also Published As

Publication number Publication date
IE811269L (en) 1981-12-09
DE3169956D1 (en) 1985-05-23
KR830006289A (ko) 1983-09-20
ZA813829B (en) 1983-01-26
PT73154B (en) 1982-07-16
PT73154A (en) 1981-07-01
ATE12771T1 (de) 1985-05-15
AU546012B2 (en) 1985-08-08
YU43235B (en) 1989-06-30
SU1217260A3 (ru) 1986-03-07
US4344943A (en) 1982-08-17
GR74615B (xx) 1984-06-29
JPS5714591A (en) 1982-01-25
EP0041711A1 (en) 1981-12-16
EP0041711B1 (en) 1985-04-17
ES502855A0 (es) 1982-04-01
IL63047A (en) 1984-07-31
ES8203376A1 (es) 1982-04-01
HU185430B (en) 1985-02-28
CA1178277A (en) 1984-11-20
YU142381A (en) 1983-12-31
AU7143881A (en) 1981-12-17
IE51523B1 (en) 1987-01-07
NZ197331A (en) 1985-05-31
KR850000609B1 (ko) 1985-05-01
IL63047A0 (en) 1981-09-13
DK249781A (da) 1981-12-10

Similar Documents

Publication Publication Date Title
YU137083A (en) Process for preparing alkylesters of 6-chloro-or 6-bromo-1,2-dihydro-3h-pyrrolo(1,2-a)pyrrol-1-carboxylic acid
IE780605L (en) 1, 2-DIHYDRO-3H-PYRROLO [1,2-a] PYRROLES
JPS5436288A (en) Thiadiazolylthiocephalosporin-family antibiotics
AU543580B2 (en) 4-hydroxy-3-quinoline carboxamides
AU8088487A (en) Use of carboxylic acid amides
NO840145L (no) Fremgangsmaate for fremstilling av terapeutisk aktive benzoyl-pyrrolo(1,2-a)pyrrol-karboksylsyre-derivater
DE3578423D1 (de) Neue cephalosporine und verfahren zu ihrer herstellung.
DE3262732D1 (en) Anthranilic acids substituted by basic groups, process for their preparation and their use
JPS5543053A (en) Preparation of optically active gamma-hydroxyundecanoic acid
ZA807905B (en) 2-phenylamino-imidazolines-(2),compositions thereof and process for the preparation thereof
JPS5612390A (en) Triazolopyridazine derivative
DK200000691A (da) Pyrrolderivater
JPS5759897A (en) Thiazolineazatidinone
JPS5553264A (en) 3-(n-substituted carbamoylthio)-2(s)-methylpropionic acid
ATE11141T1 (de) Neue cephalosporine, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
JPS53124283A (en) Preparation of 7-( alpha-substd. acetamide)-3-substd. methyl-3-cephem-4-carboxylic acid derivatives
JPS5540614A (en) Preparation of optically active n-mercaptoacyl-imino acid
JPS5251388A (en) Preparation of cephalosporanic acid dervatives
SE8107683L (sv) Xantinderivat
ES8201996A1 (es) Procedimiento para la preparacion de acidos 2,4-diamino-5- sulfamoilbenzosulfonicos sustituidos
JPS5559185A (en) Cephalosporin analog